A research team from iNANO and Department of Molecular Biology and Genetics (Aarhus University) has used an in vitro selection technique to develop an RNA molecule that recognises and binds the Spike protein from SARS-CoV-2 with very high specificity and strength. The hope is that the new molecule, known as an RNA aptamer, can help improve diagnostics and treatment of COVID-19.